+91 89899 99998info@bmwpharmaco.com
Jabalpur, Madhya Pradesh ↗WhatsApp
CallEmailWhatsApp
BMW Pharmaco

NAYACEF CV DRY SYP 162.5 MG

Composition: Cefpodoxime 100 mg + Clavulanic Acid 62.50 mg / 5ml + (W.F.I.). Pack: OUTER BOX · 30 ML. Therapy: Anti-infectives.

Product details

NAYACEF CV DRY SYP 162.5 MG pack
Composition
Cefpodoxime 100 mg + Clavulanic Acid 62.50 mg / 5ml + (W.F.I.)
Therapy
Anti-infectives
Packaging
OUTER BOX
Pack size
30 ML

Reference information

Reference is paediatric; no numeric age eligibility inferred for BMW. Prescriber must establish suitability from the actual label.

Indian manufacturer Ceftru-CV 100 page matches both active quantities per 5 ml in reconstituted dry syrup with supplied water; not BMW approval or regulator-verified prescribing information. No higher-strength age distinction or dose extrapolated. Oral use, not injection despite catalogue W.F.I. wording. Not for viral illness; susceptibility and need for combination therapy must guide selection.

  • Treatment of susceptible bacterial otitis media or sinusitis when a clinician determines that this cefpodoxime–clavulanate combination is warranted.

Reference checked: 2026-09-28

425 matching products
Showing 12 of 425
Loading more products…
Important information

Product availability, pack configuration and promotional material may vary. Please contact BMW Pharmaco for the latest commercial information. Medicines should be used only under the direction of a qualified healthcare professional.

Connect on WhatsApp